Patients stocked up on medicines early in 2020, lifting first-quarter sales for many pharmas. But that boost is likely fleeting, disguising the substantial effects the pandemic is now having on their businesses.

$NVS $LLY $PFE $BIIB $MRK

https://t.co/RIo5XeDfbt